Pharma manufacturing: people on the move

By Nick Taylor

- Last updated on GMT

Related tags Vice president presents its latest round-up of personnel changes in the pharmaceutical sector.

VIRxSYS​ has appointed Shuyuan Zhang​ to the post of senior director of production. In this capacity Zhang will focus on the late stage good manufacturing practice (GMP) manufacture of VIRxSYS’ lentiviral vectors and ex vivo patient CD4 T cell transduction and expansion for HIV treatment.

Zhang’s experience the manufacture of retroviral vectors for Phase III trials and commercial production is regarded as valuable by VIRxSYS.

Prior to joining VIRxSYS Zhang held posts at Genetic Therapy, Introgen Therapeutics and Targeted Genetics.

At these companies Zhang worked on the GMP manufacture of retroviral, adenoviral, adeno-associated viral and non-viral liposomal vector products for human gene therapy applications

Over his career Zhang has been granted five US patents for his modifications to the manufacture of retroviral and adenoviral vectors.

SAFC​ has appointed Tom Beil​ as its new vice president of quality and regulatory affairs. This will involve leading the company’s quality assurance team and overseeing all aspects of the regulatory and quality assurance programmes.

Prior to joining SAFC Beil worked as senior director of site quality at Centocor/GBSC.

Actavis​ has made senior appointments with Gudbjorg Eggertsdottir​ taking the post of deputy CEO and Doug Boothe​ becoming CEO of Actavis United States.

Eggertsdottir has been at Actavis since the company's merger with Delta and has worked in the pharmaceuticals industry since 1976.

Doug Boothe joined Actavis through the acquisition of Alpharma in 2005 and since then has held a variety of management positions within the company.

China-based Benda Pharmaceutical​ has appointed George Zhou​ as its new chief operating officer.

Zhou was co-founder, president and CEO of Abepharma and was on the board of Red Mountain Pharmaceuticals. He was also a co-founder and CEO of Kangjian.

Bristol-Myers Squibb​ (BMS) has appointed Quentin Roach​ to the post of chief procurement officer and senior vice president.

Roach will take responsiblity for managing relationships with suppliers, sourcing strategies and procurement of materials and services.

Prior to joining BMS Roach worked as vice president, global customer strategy and process management at Bausch & Lomb.

Related topics Markets & Regulations

Related news

Show more

Follow us


View more